Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05489068 · ClinicalTrials.gov registry record · NA
Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment
A NA study of Substance-Related Disorders and Treatment Adherence, sponsored by University of New Mexi.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05489068: Recruiting NA study of Substance-Related Disorders and Treatment Adherence, sponsored by University of New Mexi.
NCT05489068 is a NA study of Substance-Related Disorders and Treatment Adherence that is actively recruiting participants, run by University of New Mexi. The registered enrollment target is 150 participants, below the 1,519-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05489068, a NA study of Substance-Related Disorders and Treatment Adherence, is actively recruiting participants, sponsored by University of New Mexi.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This K23 study is an effectiveness-implementation hybrid type I design to determine the effectiveness of Motivational Interviewing at Intake (MII), relative to intake-as-usual on client engagement and mechanisms of engagement among adults seeking outpatient addiction treatment. We also will obtain personnel feedback on the feasibility of implementing MII into standard practice by having personnel from the addiction treatment study sites complete implementation climate measures before Motivational Interviewing (MI) training and post-clinical trial, as well as an individual interview on implementation feasibility post-trial.
Primary Outcome
Treatment entry is determined by review of electronic medical record of whether clients attended their first scheduled treatment session
Conditions Studied
Interventions
- BEHAVIORAL Motivational Interviewing at Intake (MII)
- BEHAVIORAL Intake as Usual (IAU)
Study Locations (1)
New Mexico
- UNM Psychology Clinic - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-03-16 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
What NCT05489068 shows while recruiting
NCT05489068 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,519-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Substance-Related Disorders appearing as the primary indexed condition, and to 2 interventions - of which Motivational Interviewing at Intake (MII) is the first listed.
NCT05489068 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT05489068 about?
NCT05489068 is a clinical study titled "Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment". This K23 study is an effectiveness-implementation hybrid type I design to determine the effectiveness of Motivational Interviewing at Intake (MII), relative to intake-as-usual on client engagement and mechanisms of engagement among adults seeking outpatient addiction treatment. We also will obtain p...
What is the current status of trial NCT05489068?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2022-03-16. Estimated completion is 2026-12-01.
What conditions does trial NCT05489068 study?
This clinical trial studies the following conditions: Substance-Related Disorders, Treatment Adherence.
What interventions are being tested in trial NCT05489068?
The interventions under investigation include: Motivational Interviewing at Intake (MII) (BEHAVIORAL), Intake as Usual (IAU) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05489068?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05489068 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05489068's enrollment target sits among peer trials
150 27th of 58 higher than 32 of 58 other Substance-Related Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families
RECRUITING · NA
-
Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions
RECRUITING · NA
-
Feasibility of the 5-Step Method in the U.S.
RECRUITING · NA
-
Whole Health in VA Mental Health: Omnis Salutis
RECRUITING · NA
-
Expression of Stress Markers During Meth Treatment (EXPRESS+)
RECRUITING · NA
-
Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI